SynthesisSensors (Basel, Switzerland)2026
Electrophysiological Signatures of Sarcopenia: A Systematic Review of sEMG Features, Fatigue Indices and AI-Based Classifiers.
Synthesis in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Age-related sarcopenia involves structural and functional neuromuscular changes. Electrophysiological measures from surface electromyography (sEMG) capture activation dynamics, spectral fatigue indices and motor unit properties that may constitute objective signatures of sarcopenia. The objective of this work is to systematically review sEMG features, fatigability metrics and AI-based classification/regression approaches reported for sarcopenia assessment between 2019 and 2026. PRISMA guidelines were followed, and IEEE Xplore, PubMed and Scopus were searched for open access human studies. Extracted information comprised sample characteristics, muscles and tasks, signal acquisition and preprocessing, extracted time/frequency/time-frequency and motor unit features, fatigue metrics, machine learning pipelines, validation schemes and dataset accessibility. Studies were classified into activation, fatigue, ML, and neural control groups; risk of bias was assessed. A total of 12 studies fulfilled the inclusion criteria. Recurrent electrophysiological signatures included reduced distal activation with compensatory proximal recruitment and higher antagonist co-activation; diminished MF/IMDF fatigue slopes indicative of Type II fiber loss and altered motor unit recruitment; motor unit analyses revealed decreased discharge rates and larger MUAP amplitudes. AI-based models combining multidomain features (time, spectral, CWT/EMD, and motor unit metrics) yielded reasonable screening performance (AUC/accuracy 0.73-0.89) when using robust feature selection and explainability tools. Heterogeneity in acquisition, normalization, small cohorts and sparse data sharing limited comparability and external validity. The findings indicate that sEMG-derived electrophysiological signatures are promising for sarcopenia detection and monitoring. To translate signatures into reliable clinical tools, standardized protocols, larger shared datasets, multimodal features, including motor unit metrics, and rigorous external validation of AI models are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.